The top 100 list of overexpressed clones (Supplementary Table 3http://www.icr.ac.uk/array/array.html) showed a small overlap (six genes) with both the previous two top 100 lists and included two further recognised markers of prostate cancer: FASN and FOLH1 (PSMA). This evidence concerns the gene FASN and prostate carcinoma.